Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Post by Smokey1958on Sep 07, 2021 2:06pm
241 Views
Post# 33819571

Don’t Miss Out!

Don’t Miss Out!

Morningstar's Fair Value sp is at $.61 and the 1-star speculative valuation is steady at $1.41. After a HOLD last week Barchart had THRM at a 64% BUY on Friday which has moved up to a 72% STRONG BUY today ....with a strengthening shorterm outlook. The resistance levels are $.55, $.58 and $.65. While the strongest support is still found around $.45 and consolidation a possibility ....it is clear over the last couple of days that NO serious investors want to be left behind.

As vaccination rates remain relatively static, testing will be the only course to some sense of "normalcy". FDA EUA authorization any day now??? Let's hope so for both the public at large and investors.

...from the article below...

"We're not where we need to be. It just takes one mistake, one infection and control error, one missed rapid test, one missed opportunity to detect the virus. Once it gets in that home, it causes havoc," she said. 

https://www.cbc.ca/news/canada/toronto/2-residents-die-in-covid-19-outbreak-at-oshawa-long-term-care-home-1.6166284

GLTE ...holding patiently!!!


 

<< Previous
Bullboard Posts
Next >>